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Abstract 
 
A prolonged imbalance between a relative increase in energy intake over a decrease in energy 
expenditure results in the development of obesity; extended periods of a positive energy balance 
eventually lead to the accumulation of abnormally high amounts of fat in adipose tissue but also 
in other organs. Obesity is considered a clinical state of impaired general heath in which the 
excessive increase in adipose tissue mass may be associated with metabolic disorders such as 
type 2 diabetes mellitus, hyperlipidemia, hypertension and cardiovascular diseases. This review 
discusses briefly the use of animal models for the study of obesity and its comorbidities. 
Generally, most studies are performed with rodents, such as diet induced obesity and genetic 
models. Here, we focus specifically on two different species, namely dogs and cats. Obese dogs 
and cats show many features of human obesity. Interestingly, however, dogs and cats differ from 
each other in certain aspects because even though obese dogs may become insulin resistant, 
this does not result in the development of diabetes mellitus. In fact, diabetes in dogs is typically 
not associated with obesity because dogs present a type 1 diabetes-like syndrome. On the other 
hand, obese cats often develop diabetes mellitus which shares many features with human type 2 
diabetes; feline and human diabetes are similar in respect to their pathophysiology, underlying 
risk factors and treatment strategies. Our review discusses genetic and endocrine factors in 
obesity, discusses obesity induced changes in lipid metabolism and includes some recent 
findings on the role of gut microbiota in obesity. Compared to research in rodent models, the 
array of available techniques and tools is unfortunately still rather limited in dogs and cats. 
Hence, even though physiological and pathophysiological phenomena are well described in 
dogs and cats, the underlying mechanisms are often not known and studies investigating 
causality specifically are scarce. 
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1. Introduction 
Obesity results from a prolonged imbalance between a relative increase in energy intake over a 
decrease in energy expenditure which is often associated with lower physical activity; the 
prolonged positive energy balance leads to the accumulation of abnormally high amounts of fat. 
In humans, obesity is defined as a clinical state of impaired general heath in which an excessive 
increase in adipose tissue mass may be associated with metabolic disorders. Excessive weight 
gain and obesity have become epidemic in industrialized countries, but the incidence of obesity 
also increases rapidly in developing countries worldwide. The pathological importance of obesity 
in humans relates to the increased mortality risk and predisposition to a variety of severe 
diseases such as type 2 diabetes mellitus, hyperlipidemia, hypertension and cardiovascular 
diseases (Kopelman, 2000). Obesity and its co-morbidities have become a serious medical 
concern not only in humans but also in other species with naturally occurring obesity. In the past 
decades, the incidence of obesity in companion animals in general and in dogs and cats in 
particular has increased dramatically perhaps even in a more extreme way than in humans, and 
it has become a serious concern in veterinary medicine (German, 2006). 
The genetic predisposition to obesity is considered a key contributing factor for the development 
of the disease. However, spontaneous single gene mutations (such as leptin deficiency or leptin 
receptor deficiency) affect only a small number of individuals in the obese population. 
Considering the rapid rise in the obesity epidemic in recent decades, human obesity is thought 
to be a polygenic disorder resulting from the integrated activity of many genes; these genes may 
then contribute to obesity when individuals are exposed to the current obesogenic environment. 
In other words, only the combined effect of genetic predisposition and of environmental and 
behavioral factors can explain the marked rise in obesity worldwide (Speakman et al., 2008).  
Current therapeutic strategies of obesity include dietary and lifestyle management, behavioral 
modification, medical and surgical therapy. The former strategies have been rather unsuccessful 
on a population-wide basis. Many of the therapeutic strategies adopted in humans are also 
available in companion animals, although with a few exceptions pharmaceutical compounds are 
not licensed yet; surgical approaches are not yet considered ethically acceptable for weight loss 
in dogs and cats (German, 2006). 
 
A fundamental contribution to the actual understanding of the etiopathogenesis of obesity has 
been provided by studies in animal models. Most frequently, rodent models have been widely 
used to investigate causes and potential treatments for obesity. In these species, obesity can be 
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induced experimentally by genetic modifications or dietary interventions such as high fat feeding 
(Lutz and Woods, 2012). Findings based on rodent studies have provided a vast amount of 
information and have elucidated many aspects of rodent obesity; however, it has to be kept in 
mind that there is not always a strong correlation to human obesity and its co-morbidities. To 
name just one example, obesity related effects on lipid and lipoprotein metabolism can often not 
be directly translated to humans because rodents’ lipoprotein and cholesterol metabolism differs 
from that in humans; this results in a different profile of the major lipoproteins very low-density 
(VLDL), low-densitiy (LDL) and high-density (HDL) lipoproteins (Breslow, 1993).  
Further, the obesogenic pathophysiology in rodents differs from that in humans in many aspects 
e.g. the dietary composition of human diets is generally much more complex than formulated 
rodent diets, and there are important strain differences in rodents so that the same strain of 
rodent from different breeders may show significant phenotypic variability in the metabolism (Lai 
et al., 2014).  
Therefore, the genetic and physiological basis and the environmental factors predisposing to 
obesity have also been studied in “alternative” animal models, such as nonhuman primates, 
dogs and cats in which obesity and its co-morbidities occur spontaneously. Hence, the rising 
epidemic and a continuing need for the development of new therapeutics make imperative to 
intensify the animal research also in “alternative” animal models in order to accelerate and 
broaden our understanding of disease mechanisms and of potential differences of human and 
animal obesity. 
 
Previous reviews have extensively summarized the most important studies performed in rodent 
models for the understanding of the physiology and genetic basis of obesity (Lutz and Woods, 
2012; Speakman et al., 2008). Accordingly, we will only briefly review small rodent work and 
focus on obesity in cats and dogs. Interestingly, these two species spontaneously develop two of 
the major metabolic disorders in humans, i.e. a type 2 diabetes-like disease in cats and a type 1 
diabetes-like disease in dogs, respectively. We will extensively overview the literature on 
experimental and epidemiological findings relating to obesity in these two species. 
 
2. Epidemiology and etiology of obesity 
In humans, the most widely used measure of body composition is the body mass index (BMI), 
defined as the weight in kilograms divided by the height in meters squared (kg/m2); despite its 
limitations (e.g., in people with a very high muscle mass) in a vast part of the population, 
changes in the BMI reflect changes in fat mass because lean body mass is fairly stable in most 
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adults. The World Health Organization (WHO) and the National Institutes of Health (NIH) defined 
overweight as having a BMI between 25.0 and 29.9 kg/m2; and obesity as having a BMI greater 
than 30.0 kg/m2. The WHO monitors the prevalence of obesity around the world and estimates 
that it has nearly doubled between 1980 and 2008 in adults and children. In 2008, 35% of adults 
were overweight and 10% of men and 14% of women were obese, compared with 5% for men 
and 8% for women in 1980 (Rennie and Jebb, 2005). WHO further projects that, by 2015, 
approximately 2.3 billion adults will be overweight and that at least 700 million will be obese 
(http://www.who.int/mediacentre/factsheets/fs311/en/; as of November 2014).  
The prevalence of raised BMI varies significantly throughout the world, ranging from low values 
in South East Asia, where 3% or less of the population are obese, to the Americas and Pacific 
Islands, where the prevalence of obesity amounts to up to 26% and 80%, respectively. 
Interestingly, worldwide, markedly more women are obese than men, with roughly twice the 
obesity prevalence of that in men in regions such as Africa, Eastern Mediterranean and South 
East Asia. The prevalence of overweight and obesity increases to more than double in high 
income and upper middle income countries compared to low and lower middle income countries. 
However, within most of high income countries, there is an inverse correlation between income 
and education and obesity (http:// www.who.int/nmh/publications/ncd_report_chapter1.pdf; as of 
November 2014).  
Obesity is associated with an increased risk for chronic metabolic diseases and death. 
Prospective studies estimate that mortality rates increase with increasing degrees of overweight, 
as measured by body mass index (see: Prospective Studies Collaboration, 2009 doi: 
10.1016/S0140-6736(09)60318-4).  
 
Dogs and cats 
In Western countries, the obesity in dogs and cats is considered the most common nutritional 
disorder in companion animals (German, 2006). Similar to the situation in humans, the 
prevalence of obesity has increased in the pet population. Older reports suggested that 24% of 
dogs (Edney and Smith, 1986) and 6–12% of cats were overweight while recently published 
studies reported a prevalence of 29–34% of overweight and of 5–8% of obese dogs and of 19–
29% and 6–8% of overweight or obese cats, respectively. In the United States, it is estimated 
that 55% of dogs and 53% of cats are overweight or obese (German et al., 2010; Lund E.M., 
2006; Lund EM, 2005). 
There are different systems for evaluating body composition in dogs and cats; the Body 
Condition Score (BCS) being the most widely accepted because the BCS is easy to use but still 
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seems to provide reliable information within and between individuals estimating the animals’ 
body condition. Dogs and cats are considered clinically overweight or obese when body weight 
exceeds ideal body weight for body size by 15 or 30%, respectively (de Godoy and Swanson, 
2013). Because the incidence of obesity in pets seems to increase in parallel with the increasing 
incidence of obesity in humans, the etiology of obesity has been thought to share many 
similarities. 
The causes of obesity in pets, as in humans, are multifactorial; obesity may result from a 
reduced energy requirement due to decreased levels of exercise, as well as from having ad 
libitum access to food (German, 2006). Although obesity is ultimately related to the energy 
equation with an imbalance between energy intake and expenditure, social and environmental 
conditions may play a major role in the development of the disease in companion animals; the 
latter are a consequence of domestication and increased anthropomorphism (de Godoy and 
Swanson, 2013; Rand et al., 2004). Most of our pets live indoors and are not obliged to compete 
for food resources (Rand et al., 2004). Major risk factors for dog obesity are breed 
predisposition, age, gender, gonadal status and neutering, and hormonal influences. For feline 
obesity, the recognized factors with significant roles in the development of obesity are inactivity, 
middle age, male gender, neutering, age at neutering and breed (Scarlett et al., 1994) (Russell 
et al., 2000). Obesity tends to be more common in younger female dogs, but both males and 
females have a similar incidence of approximately 40% when they are older than 12 years of 
age (McGreevy et al., 2005) (Zoran, 2010). Because pets reduce their metabolic rate with age, 
they may be more prone to developing obesity irrespective of their sex.  
Like in humans, obesity has detrimental effects on the animals’ health and increases mortality 
risk in companion animals. Interestingly, recent studies in a group of age-matched, pair-fed 
Labrador retrievers showed that lean dogs have a significant increase in their median life span of 
nearly 2.5 years and a significant delay in the onset of signs of chronic diseases compared to 
obese dogs (Kealy et al., 2002). Overweight and obesity in dogs may predispose to higher 
incidences of orthopedic disease, cardiorespiratory disease and hypertension, urinary tract and 
reproductive disorders, some forms of cancer, dermatological disorders and increased risk of 
anesthetic and surgical complications, hence comorbidities which are very similar to humans 
(German, 2006). Hyperlipidemia and dyslipidemia are also common findings in obese dogs. In 
cats, obesity raises the risk of developing endocrine and metabolic diseases such as diabetes 
mellitus, hepatic lipidosis, urinary tract disease, lameness and dermatopathies (Raffan, 2013).  
 
3. Genetic basis of obesity 
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The hereditability estimates for human obesity range from approximately 40% to 70% (Day and 
Loos, 2011). In the vast majority of cases, obesity is not a monogenic disease but polygenic 
traits with different genetic variations and high hereditability predispose individuals to the 
development of obesity. Genome-wide studies in humans revealed the presence of numerous 
susceptibility genes associated with the predisposition to obesity (Day and Loos, 2011). 
Importantly, such gene variability increases an individual's susceptibility or predisposition to 
develop a characteristic or a certain disease but the inheritance of such mutation alone is not 
sufficient to induce the development of the symptoms (Bouchard et al., 1990; Kopelman, 2000). 
In other words, certain environmental factors are typically necessary to induce obesity in the 
affected individual. It is worth mentioning that the phenotypic effects of a majority of the identified 
polymorphisms are small and that monogenic disorders, which often result in marked effects, are 
rare in humans (1–6% of obese subjects) and are caused mostly by mutations of the FTO and 
melanocortin-4 receptor (MC4R) genes (Farooqi and O'Rahilly, 2007; Razquin et al., 2011; 
Santini et al., 2009; Wardle et al., 2008). The MC4R is a transmembrane G-protein–coupled 
receptor which plays an important role in the control of energy balance and appetite. This 
receptor is encoded by a single exon and is mainly expressed in the hypothalamus. MC4R gene 
mutations are the most common single genetic cause of hereditary human obesity accounting 
for up to 6% of cases (Tao, 2010). 
 
Spontaneous single-gene mutations leading to marked obesity in rodent models have been 
recognized since the 1950s; i.e. long before the underlying genetic defects were discovered. 
Greater insight into the underlying mechanisms has been fueled by the identification of the 
adipocyte-derived hormone leptin and its receptors both of which were first characterized in 
1994 in an inbred strain of morbidly obese mice, the leptin deficient ob/ob model (Lee et al., 
1996; Zhang et al., 1994) and were further characterized in the leptin receptor defective db/db 
mutant mice (Chen et al., 1996; Hummel et al., 1966; Maffei et al., 1995). Since then, research 
in the field of genetics of obesity and control of energy metabolism increased dramatically and 
resulted in the identification of several candidate genes associated with human obesity and to 
the subsequent use of spontaneous mutants or generation of engineered mutants. Some of the 
most commonly used rodent models of obesity are the ob/ob mouse, the db/db mouse, its rat 
counterparts like the Zucker rat and the MC4R deficient animals (Lutz and Woods, 2012).  
 
Dogs and cats 
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The dog and the cat are considered good comparative models for human obesity, since clinical 
signs and the genetic background of obesity are similar in the three species. Because dogs and 
cats share our same environment, often including the abundance of food, they may be 
predisposed to similar genetic-based pathophysiologies if the environment favours the 
expression of certain genetic traits (Lindblad-Toh et al., 2005). Similarly to the findings in 
humans, it is likely that overweight and obesity in pets are influenced by genetics. Strong breed 
predispositions to obesity were found in Labrador retrievers, Boxers, Cairn terriers, Scottish 
terriers, Shetland sheepdogs, Basset hounds, Cavalier King Charles spaniels, Cocker spaniels, 
Dachshunds, Beagles (Edney and Smith, 1986). In Germany, the breeds with an increased risk 
of obesity are Boxers, Cocker spaniels, Dachshunds, Poodles and Spitz. Interestingly, some 
breeds such as greyhounds seem to be resistant to development of obesity (Zoran, 2010). 
Advanced knowledge of the canine and feline genome was completed between 2004 and 2007 
(Lindblad-Toh et al., 2005; Pontius et al., 2007). This together with the availability of powerful 
molecular tools facilitated studies for the identification of genes that are responsible for 
monogenic hereditary diseases and also for polymorphisms similar to human obesity. Extended 
studies in humans indicated that polymorphisms of genes encoding adipokines and their 
receptors are associated with obesity. In dogs, although the knowledge of the endocrine function 
of the adipose tissue and the study of adipokines is advanced, only few preliminary studies have 
been reported on the polymorphism of adipokines genes (Radin et al., 2009) (Ricci and 
Bevilacqua, 2012). 
MC4R, MC3R, FTO and PPARgamma gene polymorphisms were identified in the dog but 
unfortunately, the functional relevance of these gene polymorphisms for the pathogenesis of 
obesity was not studied (Switonski and Mankowska, 2013). Recently, some single nucleotide 
polymorphisms (SNPs) in the canine MC4R gene were identified in different cohorts of dogs. 
However, no significant associations were found between these SNPs and an increased risk of 
obesity (Skorczyk et al., 2007; van den Berg et al., 2010). Nevertheless, in Beagle dogs, two 
SNPs were shown to affect the function of the MC4R gene relative to body weight control and 
were proposed as a genetic marker for selecting different size dogs (Zeng et al., 2014).  
In cats, the sequence of feline MC4Rs was confirmed and SNPs in its coding region were 
associated with diabetes mellitus in overweight domestic shorthair cats (Forcada et al., 2014). It 
remains, however, to be established whether this is simply an association or whether a causal 
relationship may be involved. Generally, studies for the identification of genetic markers 
associated with the predisposition to obesity are rare in cats. However, a genetic study 
describing the mode of inheritance of the overweight phenotype in an experimental cat 
population was recently published. Complex segregation analysis revealed that a genetic as yet 
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unidentified component might be responsible for the development of overweight in cats (Haring 
et al., 2012). 
 
4. Endocrine component 
Obesity is one of the major risk factors for the development of several endocrine conditions and 
is associated with important metabolic and hormonal changes. The list of recognized metabolic, 
hormonal and inflammatory conditions associated with obesity increases. However, the 
development of obesity may also be secondary to endocrine disorders. Dogs and cats are 
susceptible to similar hormonal diseases and share many of the detrimental effects that are 
associated with human obesity. 
 
4.1 Adipose tissue and adipokines 
The anatomical distribution of body fat, especially the intra-abdominal visceral deposition of 
adipose tissue, plays an important role in the development of co-morbidities of obesity in 
humans. Excess of adipose tissue in the upper body has been termed android, central, or 
abdominal obesity and usually correlates better with increased mortality and the risk for type 2 
diabetes, hypertension, dyslipidemia and cardiovascular disease than the subcutaneous fat 
(Kissebah et al., 1982). This type of fat distribution is more frequently found in men, while 
women, at least before menopause, usually show greater adipose mass in the lower parts of the 
body in subcutaneous depots, which seems to have less metabolic consequences. Irrespective 
of these gender differences, women with upper body obesity are significantly more glucose 
intolerant than women with lower body obesity and are at increased risk for the occurrence of 
metabolic and cardiovascular complications (Carey et al., 1997). 
White adipose tissue is the major storage depot of excess dietary energy. It is important to note 
that the deposition of excess fat in white adipose tissue should also be considered protective for 
the rest of the body. In other words, ectopic deposition of fat e.g. in skeletal muscle or liver is per 
se associated with an increased metabolic risk (Shimabukuro et al., 2013). This is best 
exemplified in patients suffering from lipodystrophy who are unable to store fat in white adipose 
tissue. These patients who are leptin deficient suffer from massive metabolic disturbances some 
of which can actually be treated by the administration of leptin (Weber et al., 2014). 
 
White adipose tissue produces and secretes “adipokines” which either directly or indirectly 
modulate many metabolic processes. Primary adipokines (such as leptin and adiponectin) are 
produced primarily or exclusively, respectively, by adipocytes. In the face of a nutritional 
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overload, the excessive accumulation of fat in adipocytes appears to cause a condition of 
cellular stress and dysfunction, which may lead to the development of inflammatory responses of 
the adipose tissue (Pickup and Crook, 1998). Specifically, hypertrophied adipocytes are 
suggested to initiate an inflammatory response in adipose tissue via an increased secretion of 
adipokines and cytokines. Paracrine, autocrine, endocrine signals as well as adipocyte 
hyperplasia and hypertrophy are also involved in the recruitment of macrophages. Hence, the 
number of macrophages within the adipose tissue dramatically increases with increasing fat 
accumulation and correlates with adipocyte size in obesity (Weisberg et al., 2003). The 
inflammatory signals are eventually potentiated by the cross-talk between macrophages and 
adipocytes which together contribute to the overall increase in the inflammatory state in adipose 
tissue and to the development of the “low-grade” chronic inflammation associated with obesity. 
The inflammation in obesity is also characterized by an increased release of proinflammatory 
cytokines and chemokines into the general circulation and higher plasma levels of acute phase 
proteins like C-reactive protein and serum amyloid A (Hotamisligil, 2006). 
Leptin was the first adipocyte hormone identified in 1994 (Zhang et al., 1994). It is a cytokine-like 
hormone encoded by the ob gene that influences food intake and energy expenditure at least in 
part through a direct effect in the hypothalamus. The plasma leptin concentration correlates with 
body fat mass (Considine et al., 1996) and increases and decreases in response to weight gain 
or weight loss, respectively, but leptin also increases more acutely in response to food intake 
(Romon et al., 1999; Weigle et al., 1997). Leptin stimulates fatty acid -oxidation and inhibits 
lipogenesis in peripheral tissues; hence leptin functions to decrease triglyceride content in these 
tissues and to decrease fatty acid levels in the circulation. In obesity, responses to leptin are 
diminished in the hypothalamus (de Lartigue et al., 2011), and leptin-target cells become 
resistant to its actions. The resistance to leptin’s effects in the hypothalamus and the concurrent 
lowering of the body's energy metabolism may contribute to further weight gain in obese 
subjects because the brain is unable to adequately “measure” the body’s adipose tissue stores. 
Resistance to leptin action is associated with severe insulin resistance as the result of increased 
ectopic fat accumulation and lipotoxic effects in insulin-sensitive tissues.  
Because leptin is well suited to inform the brain about the availability of energy stores in adipose 
tissue, leptin is also involved in the control of many other functions in the body; to name just two 
examples, leptin modulates normal reproductive function and immune function, and it also 
modulates insulin sensitivity with opposite effects to adiponectin (see below) (Loffreda et al., 
1998). 
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Adiponectin is produced exclusively by mature adipocytes and circulates in plasma in multimeric 
form, with the high molecular weight form being the most biologically active. Its secretion is 
stimulated by insulin and by dietary constituents such as amino acids. Adiponectin levels 
inversely correlate with fat mass, hepatic lipid content and dyslipidemia, but positively with 
insulin sensitivity. Adiponectin influences glucose metabolism also by increasing glycolysis and 
fatty acid oxidation, it has anti-inflammatory properties and it is thought to play a role in the 
inhibition of the development of atherosclerosis (Kadowaki et al., 2006). Plasma levels of 
adiponectin are lower in subjects with obesity, type 2 diabetes mellitus, cardiovascular disease, 
hypertension, and metabolic syndrome compared to healthy patients (Ziemke and Mantzoros, 
2010). 
 
Dogs and cats: 
Similar to humans, the secretion of adipokines from adipose tissue seems to be dysregulated in 
obese pets (Radin et al., 2009). Visceral obesity correlates with greater insulin resistance, 
hyperinsulinemia and alterations in plasma lipoprotein and lipid levels than subcutaneous 
obesity in humans; the underlying mechanisms are still unclear but may be related to different 
levels of estrogen receptor expression in the different fat depots (Davis et al., 2013).  
In dogs and cats, the metabolic differences between excessive intra-abdominal and peripheral 
subcutaneous fat depots have not been demonstrated yet. Nonetheless, increasing fat mass 
positively correlates with serum leptin concentrations (Appleton et al., 2000) (Sagawa et al., 
2002) while weight loss results in a decrease in circulating leptin (Hoenig et al., 2007). Fat rich or 
high-energy meals increase leptin concentrations in both species (Ishioka et al., 2005) but at 
least in cats, higher circulating levels of leptin also positively correlate with insulin resistance 
regardless of the cats’ body condition score and fat mass (Appleton et al., 2002). Similar to 
experimental rodents, there is evidence that the leptin transport through the blood-brain barrier is 
defective in obese dogs (Nishii et al., 2006).  
Interestingly, the ob gene seems to be expressed exclusively by pre-adipocytes and mature 
adipocytes from white adipose tissue of dogs but no expression in any other tissue (e.g., in the 
stomach where it is found in rodents) was observed (Eisele et al., 2005). In dogs, breed, 
glucocorticosteroid therapy and the feeding status may influence circulating leptin concentrations 
(Ishioka et al., 2005; Nishii et al., 2006). The association between increased leptin levels and 
neutering in both female and male cats is most probably related to the increase in fat mass 
gained post-neutering (Martin et al., 2006). However, a causal inter-relationship between leptin, 
insulin resistance and diabetes has not been demonstrated in cats (Appleton et al., 2002).  
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Similar to other species, adiponectin is produced and secreted exclusively by mature adipocytes 
in both dogs and cats, and it shows a strong homology to adiponectin in other species (Brunson 
et al., 2007) (Ishioka et al., 2006). Plasma adiponectin concentrations negatively correlate with 
increased fat mass, and most studies report that circulating levels of adiponectin are significantly 
lower in obese than in normal-weight dogs and cats (Hoenig et al., 2007) (Ishioka et al., 2009) 
(Grant et al., 2011; Muranaka et al., 2010).  
In cats, adiponectin gene expression is significantly higher in visceral than other adipose depots 
(Ishioka et al., 2009; Zini et al., 2009a). Recent reports showed that the high molecular weight 
(HMW) multimers of adiponectin account for about 80% of total adiponectin in cats while they 
only account for 30% of total adiponectin in humans (Kaser et al., 2008) (Lusby et al., 2009). 
Dogs also appear to have a greater HMW adiponectin concentration than humans (Verkest et 
al., 2011b). HMW multimers are more active and are more closely associated with insulin 
sensitivity and body fat mass than total adiponectin (Lusby et al., 2009). In contrast to humans, 
dog obesity does not seem to be associated with selectively reduced HMW adiponectin. Thus, 
adiponectin may be a less important biomarker of canine obesity-associated insulin resistance. 
Further, one study reported that total adiponectin levels are lower in obese neutered male than 
in female cats; this difference was not related to larger total body size and fat mass in male cats 
(Bjornvad et al., 2014). This gender difference may also not be directly attributable to sex 
hormones, since the levels of testosterone which is known to directly decrease adiponectin 
levels in humans and rodents (Combs et al., 2003; Nishizawa et al., 2002), are expected to be 
minimal in neutered male cats (Bjornvad et al., 2014). However, in other feline studies, 
adipokines levels were reported to be similar between male and female cats (Hoenig et al., 
2007; Muranaka et al., 2010). The role of adiponectin as anti-inflammatory adipokine has not 
been investigated in cats.  
 
There are only few studies in dogs and cats that directly addressed the role of proinflammatory 
cytokines in the pathogenesis of obesity. It has been shown that almost 50% of dogs with 
naturally occurring obesity had increased concentrations of circulating TNF-α, C-reactive protein 
and haptoglobin; all three parameters decreased significantly after weight loss (German et al., 
2009). In an another study, 30 weeks of overfeeding caused insulin resistance in dogs which 
was associated with increased plasma TNF-α, insulin-like growth factor, and non-esterified fatty 
acid concentrations (Gayet et al., 2004). In contrast to human studies, C-reactive protein 
concentrations were decreased significantly in insulin resistant obese dogs (Veiga et al., 2008). 
Several studies in cats have shown that TNF-α expression in adipose tissue and in skeletal 
muscle is increased in obese cats (Hoenig et al., 2006; Miller et al., 1998). Further, obesity was 
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associated with increased adipocyte cell size and increased gene expression of pro-
inflammatory cytokines and chemokines; surprisingly, the latter was more pronounced in 
subcutaneous than in visceral adipose tissue. Further the number of T-lymphocytes but not of B-
lymphocytes or macrophages was increased in the adipose tissue of obese cats (Van de Velde 
et al., 2013). However, the role of inflammation in the development of obesity-induced insulin 
resistance has been discussed controversially in cats. Some studies, in fact, reported no 
changes in anti-oxidant enzymes’ activity or inflammatory cytokines in obese cats (Hoenig et al., 
2013; Jaso-Friedmann et al., 2008). Moreover, assays for the quantification of feline circulating 
cytokines and chemokines are currently not available or have not been validated appropriately. 
 
4.2 Insulin resistance and diabetes 
Insulin resistance is a state of reduced responsiveness of insulin-target tissues to normal 
circulating levels of insulin (Lozinski and Frohlich, 1942). Insulin resistance results from genetic 
or acquired factors; however, the most common type of insulin resistance is associated with 
overweight and obesity in a condition which, at least in humans and cats, often progresses to 
type 2 diabetes mellitus. The combination of genetic and environmental factors in peripheral 
insulin resistance generates deficits in the insulin signal transduction. Early studies suggested 
that circulating free fatty acids are elevated in many insulin-resistant states and that they 
compete with glucose for substrate oxidation in diabetes and obesity (Randle et al., 1963). 
Increased free fatty acids levels counteract the effects of insulin by inhibiting glucose uptake, 
glycogen synthesis and glucose oxidation, and by increasing hepatic gluconeogenesis which 
contributes to increased blood glucose levels. Quantitatively, skeletal muscle has long been 
considered the primary site for insulin-stimulated glucose uptake, with adipose tissue 
contributing less to whole-body glucose disposal in the insulin stimulated state and following the 
consumption of mixed meals. In insulin resistant states, pancreatic -cells initially increase 
insulin secretion to adequately compensate for the diminished insulin sensitivity and the 
resultant increase in plasma glucose levels (Hull et al., 2004). Concurrent with the effects of 
hyperinsulinemia, abnormalities in amylin secretion, and in particular abnormalities in the 
processing of amylin and its deposition as amyloid in the islets may be responsible for the 
progressive loss of -cells in human type 2 diabetes mellitus. Studies in several animal species 
with naturally occurring amylin derived-amyloid (such as cats and primates, but not rodents) and 
in transgenic rats and mice expressing the human amyloidogenic form of amylin demonstrated 
that islet amyloid formation plays a key role in β-cell apoptosis and dysfunction (Ma et al., 2000; 
Westermark et al., 2000). Amylin oligomers which are formed in the early stages of fibril 
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aggregation seem to be the principle toxic entity responsible for amylin-mediated β-cell 
cytotoxicity and death. The toxicity of amyloid or oligomers deposition relies on different 
mechanisms that act together intra- and extracellulary (Lorenzo et al., 1994). Aggregated amylin 
has been recently suggested to have inflammatory properties. Soluble oligomers of amylin may 
activate the inflammasome, a multiprotein oligomer expressed in myeloid cells and components 
of the innate immune system, to produce proinflammatory cytokines which are toxic to β-cells 
(Donath and Shoelson, 2011; Masters et al., 2010). The worsening of insulin resistance together 
with abnormalities in compensatory insulin secretion may eventually lead to the development of 
type 2 diabetes mellitus (Hull et al., 2004). 
 
Dogs and cats 
Obesity-induced insulin resistance and hyperinsulinemia have been observed in dogs (Gayet et 
al., 2004). The degree of insulin resistance associated with diet-induced obesity appears to be 
dependent on age, with older dogs being more insulin resistant than young dogs (Serisier et al., 
2008). Weight loss leads to a recovery of insulin sensitivity and decreased insulin concentrations 
(Diez et al., 2004) (Yamka et al., 2006). Contrary to obese humans and cats, insulin resistance 
in obese dogs does not spontaneously progress to type 2 diabetes mellitus (Verkest et al., 
2011a; Verkest et al., 2012)_ENREF_74.  
Dogs might be protected from the development of type 2 diabetes by either compensating 
adequately for obesity-induced insulin resistance or by additional factors. Obese dogs appear to 
compensate for years of insulin resistance by maintaining high fasting insulin concentrations and 
an increased first-phase insulin secretion during glucose tolerance tests (Verkest et al., 2012). 
Other factors may also protect dogs from obesity-induced diabetes, i.e. factors that are involved 
in the pathophysiology of β-cell failure in humans and cats but not in dogs. The most important 
of these factors may be the lack of amylin derived islet amyloid in canine diabetes. Contrary to 
humans and cats, canine amylin does not aggregate and form pancreatic islet amyloid in 
diabetes. Therefore, because islet amyloid is absent in obese and diabetic dogs, this species 
may be protected from the development of diabetes mellitus in obesity. Nonetheless, amylin-
derived amyloid deposits have been observed in dogs with insulinomas which supports the 
concept that in addition to an amyloidogenic property of the amylin molecule and high local 
amylin concentrations, a defect in amylin processing may predispose to its aggregation into 
amyloid fibrils (Jordan et al., 1990; O'Brien et al., 1990). 
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In obese cats, insulin sensitivity is typically decreased by more than 50% compared to healthy 
lean animals (Appleton et al., 2001; Hoenig et al., 2007). Each kilogram of weight gain leads to a 
loss of about 30% in insulin sensitivity and glucose effectiveness in cats (Hoenig et al., 2007). 
Cats with naturally low insulin sensitivity are at increased risk of becoming glucose intolerant 
with weight gain. Interestingly, obese male cats have lower innate insulin sensitivity and higher 
basal insulin concentrations and therefore are probably more prone to diabetes than obese 
females which is consistent with epidemiological data (Appleton et al., 2001). This also reflects 
the situation in humans where males are at higher risk of developing type 2 diabetes than 
females, at least up to the age of menopause. Obesity induced insulin resistance is reversible 
because weight loss improved insulin sensitivity and reduced hyperinsulinemia in overweight 
cats (Biourge et al., 1997; Tvarijonaviciute et al., 2012). 
As a strict carnivore, cats have a reduced ability to metabolize large carbohydrate loads, most 
likely due to the limited activity of liver glucokinase. To maintain euglycemia, cats rely on higher 
activity of enzymes related to energy metabolism such as hexokinases. It is however still 
controversial whether cats may regulate gluconeogenesis and endogenous glucose production 
in response to diet changes (Hoenig et al., 2007; Rogers et al., 1977; Russell et al., 2002; Zoran, 
2002). Obese cats have high insulin levels in both the fasted and postprandial state and are 
insulin resistant in most insulin-sensitive tissues. Despite that, fasting normoglycemia is often 
maintained, and endogenous glucose production is decreased compared to lean cats. Although 
these findings are in contrast to humans, they might suggest that hepatic insulin sensitivity is still 
somewhat preserved in obese cats (Hoenig, 2014; Hoenig et al., 2011). 
Even though inter-species differences in enzyme activities have to be interpreted with caution, it 
seems that cats may be less insulin sensitive than dogs because the expression of genes 
involved in glucose and lipid metabolism is lower in insulin-sensitive tissues in cats than in dogs 
(Mori et al., 2009a; Mori et al., 2009b). Nonetheless, and similar to dogs, obese cats have an 
increased expression of lipid and carbohydrate metabolism-related genes compared to their lean 
counterparts (Brennan et al., 2004; Mori et al., 2009b). 
 
Although most obese cats seem to compensate for their peripheral insulin resistance and 
maintain normal fasting and post prandial glucose levels for extended periods (Hoenig et al., 
2012), obesity in cats is a major risk factor for the development of diabetes. In fact, obese cats 
have an almost 4 times increased risk of developing diabetes mellitus compared to cats with an 
optimal body weight (Scarlett and Donoghue, 1998). The high incidence of diabetes and in 
particular of type 2 diabetes like features in cats is probably related to -cell dysfunction and the 
resulting impairment of glucose tolerance. One important mechanism involved in -cell 
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dysfunction is the presence of amyloid deposition. Like in humans and non-human primates, 
feline amylin contains an amyloidogenic-promoting region which predisposes feline amylin to 
aggregate and to form pancreatic islet amyloid fibrils. Amylin levels are elevated in obese cats 
(Henson et al., 2011; Lutz and Rand, 1996) and amyloid deposition is a common finding in 
diabetic cats (Herndon et al., 2014; Lutz et al., 1994). However, amylin-derived amyloid is also 
present in nondiabetic age, gender and body weight matched cats, and it has been recently 
demonstrated that 56% of diabetic cats versus 42% of control cats had similar amount of 
amyloid deposition (Zini E, 2012). Further, because not all diabetic cats develop amylin derived 
amyloid, the exact contribution of amylin oligomers as a cause of β-cell dysfunction and death 
need to be further clarified in this species.  
Another important pathogenic factor of -cell dysfunction is hyperglycemia. Increased glucose 
concentrations have been shown to be detrimental and toxic for -cells in humans and in 
experimental animals. In cats, insulin therapy may be able to reverse some of the toxic effects of 
hyperglycemia by improving glycemic control (Nelson et al., 1999). However, if sustained 
hyperglycemia is induced by 10 days of glucose infusion, early and severe β-cell dysfunction is 
provoked even in healthy cats. Hyperglycemia promoted also an inflammatory response 
increasing circulating levels of inflammatory markers in healthy experimental cats (Zini et al., 
2009b).  
 
4.3 Dyslipidemia 
The most important aspects of dyslipidemia in human obesity and in the metabolic syndrome are 
the presence of small, dense low density lipoprotein particles (sdLDL), low levels of high density 
lipoprotein-cholesterol (HDL-C), and high plasma triglycerides (Grundy, 1998). A predominance 
of sd-LDL particles is strongly associated with an increased risk of coronary artery disease and 
the development of atherosclerosis in nondiabetic patients (Austin et al., 1990), and the sdLDL 
phenotype is also a consistent feature in insulin resistant subjects. sd-LDLs are thought to be 
highly atherogenic because they penetrate the arterial wall more rapidly, have a higher binding 
affinity to proteoglycans of the arterial wall, and have lower resistance to oxidative stress than 
LDLs of normal size (Chapman et al., 1998). Further, low concentrations of HDL-C are also 
associated with a higher risk of atherosclerosis and increased severity of cardiovascular disease 
in humans. In insulin resistant and hypertriglyceridemic states, the exchange of VLDL 
triglyceride for HDL-C is increased. The resultant HDL particles are enriched with TG and 
depleted of cholesterol (Rashid et al., 2003). Further, hyperglycaemic states are associated with 
increased glycation of HDL particles resulting in a reduced capacity of HDL to prevent LDL 
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oxidation (Parthasarathy et al., 1990). The hepatic overproduction of VLDLs is one of the 
hallmarks of dyslipidemia in insulin resistance and associated with compensatory 
hyperinsulinemia (Adiels et al., 2008). The inability of insulin to inhibit VLDL secretion and to 
suppress hepatic glucose production, and the increased flux of free fatty acids and glucose to 
the liver increase the production and secretion of VLDLs. VLDLs are mainly degraded from the 
circulation by lipoprotein lipase (LPL). Because insulin stimulates LPL activity, and because the 
regulation of LPL activity is impaired in insulin resistant states, VLDL clearance is decreased 
(Panarotto et al., 2002). Fasting triglyceride concentration is a major predictor of postprandial 
lipemia (Kolovou et al., 2005), and both parameters are associated with cardiovascular disease 
and abnormalities in lipid metabolism. Prolonged postprandial hypertriglyceridemia is thought to 
create metabolic perturbations such as an increase in oxidative stress and ectopic fat deposition 
which may promote atherosclerosis through peroxidation of LDLs (Heine et al., 2004).  
 
Dogs and cats 
Only few studies on changes in serum lipids exist in dogs and cats with naturally occurring 
obesity. In obese dogs, published data suggest that significant changes in lipid and lipoprotein 
metabolism occur and may be important for the development of other obesity-associated 
comorbidities. Obese dogs have been reported to have higher serum triglycerides and total 
cholesterol than lean dogs (Pena et al., 2008) (Jeusette et al., 2005). Both alterations seem to 
be reversed by weight loss (Diez et al., 2004; Jeusette et al., 2005). Lipoprotein concentrations, 
plasma nonesterified fatty acids and triglyceride concentrations increased in laboratory dogs fed 
energy-dense diets (Bailhache et al., 2003). Although such changes were associated with insulin 
resistance and hypertension (Truett et al., 1998), the prevalence of cardiovascular problems and 
atherosclerosis in obese dogs is very low. Alterations in lipid particle size in dogs may not have 
the same consequences on coronary artery disease as in humans; it is also possible that the 
shorter life span of dogs may be associated with less marked changes and subsequently a lower 
clinical relevance. Nonetheless, hypertriglyceridemia observed during obesity has been 
associated with an increased risk for pancreatitis in dogs (Chikamune et al., 1995) (Rogers et 
al., 1975). However, further studies are warranted to assess cause and effect relationships. 
 
Generally, dyslipidemia in obese cats appears to be similar to that observed in obese and 
diabetic humans including increases in NEFAs and triglycerides, decreases in HDL, and 
increases in VLDL and total cholesterol (Jordan et al., 2008). It has been shown that lipoprotein 
metabolism varies in cats as a result of age and sex and that the effects of neutering on plasma 
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lipid and lipoprotein concentrations are greater in adult compared to adolescent cats (Butterwick 
et al., 2001).  
High sdLDL and low HDL-C levels are major risk factors for atherosclerosis in obese humans; it 
is important to note that not only the total concentration of HDL determines HDL’s vasoprotective 
effects, but that their antioxidative, anti-inflammatory and cholesterol scavenging properties may 
be affected without changes in measured total HDL-C (Ansell et al., 2005); we are not aware of 
any such test having been done in cats.  
Atherogenesis and coronary artery disease are usually not observed in obese or diabetic cats or 
in fact in cats in general; we are only aware of a single study where the susceptibility to diet-
induced atherosclerosis was shown in this species (Ginzinger et al., 1997). In humans, plasma 
HDL-C concentrations are regulated by plasma cholesteryl ester transfer protein (CETP), the 
protein responsible for the transfer of cholesteryl esters from HDL to LDL and VLDL (Bauer, 
2004). In human hypercholesterolemic states, the excess of cholesterol esters-enriched VLDLs 
or LDLs overwhelms the clearing capacity of the liver and results in the accumulation of 
atherogenic apo B-containing particles enriched with cholesterol esters. Dogs, and possibly also 
cats, present with lower activity of CETP compared to other species (Tsutsumi et al., 2001). This 
peculiarity in the CETP activity may prevent the excessive transfer of cholesterol esters to 
VLDLs or LDLs and the subsequent formation of atherogenic modified LDLs in cats.  
In humans, LPL activity varies according to the different phases of obesity, being higher in the 
early phase and lower in more established obesity. In cats that were obese for at least one year, 
LPL tissue activity and tissue-specific expression were decreased in adipose tissue and 
increased in muscle compared to lean cats. These changes in LPL activity were considered as 
an adaptive response of the lipoprotein metabolism and lipid deposition and indicative of a 
redistribution of fatty acids from fat to muscle tissue during obesity (Hoenig et al., 2006). 
 
When hyperlipidemia was induced by a 10-day lipid infusion in healthy experimental cats, 
hepatic steatosis and systemic inflammation developed. However, the sustained increase in 
plasma triglyceride concentrations and the resulting increase in inflammatory processes were 
not sufficient to affect plasma insulin or glucose concentrations or whole-body insulin sensitivity, 
or result in -cell apoptosis (Zini et al., 2009b; Zini et al., 2010). Acute inflammation in humans is 
associated with transient insulin resistance and dyslipidemia. Chronic low-grade inflammation is 
a pathogenic component of insulin resistance and adipose tissue dysfunction in obesity-induced 
type 2 diabetes. Prolonged lipopolysaccharide (LPS) infusion that was sufficient to induce a 
subacute state of inflammation in cats caused acute insulin resistance, followed by long-lasting 
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tissue-specific dysfunctions of lipid-, glucose-, and insulin metabolism-related targets; this 
ultimately resulted in dyslipidemia but not whole-body insulin resistance (Osto et al., 2011). 
 
All together these studies indicate that in cats as in humans, changes in lipid and lipoprotein 
metabolism and inflammation are mutually linked. However, whether hyperlipidemia or 
inflammation are sufficient key initiating events in the development of insulin resistance and -
cell dysfunction in the absence of obesity remains to be determined in cats. 
 
4.4 Other endocrine disorders 
The prevalence of obesity increases significantly in women after menopause (Flegal et al., 
2012). In rodents, gonadectomy in females leads to an increase in body weight associated with 
an initial increase in eating. The lack of estradiol seems to be the critical obesity-triggering factor 
(Clegg, 2012) since gonadal steroids and in particular estradiol reduce food intake via a variety 
of peripheral feedback controls of eating including cholecystokinin, glucagon, hepatic fatty acid 
oxidation, insulin and leptin (Asarian and Geary, 2006) (Asarian and Geary, 2013). 
 
Neutering has been shown to induce changes in basal metabolism and to be one of the major 
risk factors for canine and feline obesity. Interestingly, the incidence of obesity is higher in 
spayed female dogs than in neutered males (Edney and Smith, 1986; Mao et al., 2013), and 
d_ENREF_7aily food intake is higher in neutered compared to ovariohysterectomised dogs (Houpt 
et al., 1979). Another study found that female dogs have a significant decrease in daily energy 
expenditure after ovariectomy which may also contribute to the neutering induced obesity risk 
(Jeusette et al., 2004).  
In cats, gonadectomy is also associated with an increased body weight gain and elevated risk 
for obesity (Kanchuk et al., 2003) (Nguyen et al., 2004). This may result from increased food 
intake, since neutered cats eat more as early as 3 days after surgery compared to intact cats 
(Kanchuk et al., 2003). The contribution of lower energy expenditure to the increase in body 
weight is not yet clear because energy expenditure was reported not to decrease after 
gonadectomy in neutered cats fed ad libitum in a number of studies (Kanchuk et al., 2003) 
(Martin et al., 2006).  
In female rats and mice, it has been demonstrated that gonadectomy removes the estrogenic 
inhibition of eating (Asarian and Geary, 2002, 2006) and that these changes are reversed by 
physiological estradiol treatment (Geary et al., 1994). Withdrawal of estradiol following 
ovariectomy or menopause is sensed centrally and influences brain centers that control food 
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intake and energy metabolism, resulting in increased energy intake, body weight and fat 
accumulation (Kanchuk et al., 2003; Martin et al., 2006)_ENREF_50. In principle, consistent with 
these reports, daily pharmacological administration of estradiol prevented the increase in food 
intake and body weight following gonadectomy in both male and female overweight cats (Cave 
et al., 2007b). However, data from studies with a physiological pattern of estradiol replacement 
or data regarding the relationship between the release of sex hormones after gonadectomy and 
the development of obesity in dogs and cats are scarce.  
 
The role of changes in thyroid hormones for the development of obesity is considered 
controversial in dogs. In one study, obese dogs had normal thyroid function with only slightly 
increased total T4 and T3 concentrations (Daminet et al., 2003). On the contrary, a more recent 
study showed that 42% of obese dogs had increased TSH and decreased free T4 
concentrations, i.e. biochemical evidence indicative of subclinical hypothyroidism. The 
prevalence of hypothyroidism is however very low in dogs (Daminet et al., 2003) and it is unlikely 
to be considered a major reason for general obesity.  
In obese cats, free serum T4 concentrations are increased significantly but total T4 and TSH 
concentrations are normal (Ferguson et al., 2007). However, whether there is a cause-effect 
relationship between obesity and thyroid dysfunction is still not clear. Hence, the situation is 
similar to humans. 
 
4.5 Diet-induced obesity and body-weight loss 
Rodent models of diet-induced obesity are broadly used to study polygenic causes of obesity. 
The diet-induced obesity paradigm seems to better reproduce the state of common obesity in 
humans than most of the genetically modified models, including the control of food intake when 
individuals are exposed to high fat food (Lutz and Woods, 2012). 
Feeding rats with a varied and palatable diet which mimic the “cafeteria”, “western type” diet 
often result in the development of obesity and hyperphagia (Perez et al., 1999). In non–human 
primates and rodents, it has been observed that the development of obesity in response to high 
fat or high-fat-sucrose diets is species- and strain-dependent (Speakman et al., 2008). Most 
interestingly, even within the same strain, some animals seem to be resistant to weight gain 
when fed with high-fat diets and are therefore called diet resistant. 
The rodent models of diet-induced obesity (DIO) share several physiological and genetic 
mechanisms with human obesity. Importantly, DIO in rodents and humans is an inherited 
polygenic trait whose phenotypic expression is exacerbated by exposure to high energy diets 
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(Levin et al., 1997). DIO individuals and rodents develop the metabolic syndrome with insulin 
and leptin resistance, hyperlipidemia, and hypertension when the caloric density and fat content 
of the diet are increased (Levin and Dunn-Meynell, 2000; Levin et al., 1997; Levin and Routh, 
1996). Studies on the effects of high fat diet feeding in rodent models of obesity have been 
previously extensively reviewed (Lutz and Woods, 2012; Speakman et al., 2008). 
 
Obviously, physical activity and food intake are the two most important factors involved in body 
weight control. Body weight loss and maintenance of this body condition in humans is achieved 
mostly by restriction of dietary carbohydrate and fat intake both during and after weight loss. An 
important concern with energy restricted diet, however, is the increase in hedonic hunger and 
decreases in the feeling of fullness, both factors which increase the risk for body weight regain 
(Martinez et al., 2014). In addition, fat loss during weight loss programs should be accomplished 
while maintaining energy expenditure and lean body mass. Among the variety of dietary 
interventions which have been designed to reduce energy intake, the use of moderately high-
protein diets (<35% of total calories) and low-carbohydrate and fibre-rich foods has been shown 
to be more effective in inducing satiety and reducing weight gain (Abete et al., 2008; Halton and 
Hu, 2004; Martens and Westerterp-Plantenga, 2014). However, the long-term effects on weight 
control of low-carbohydrate diets is often not sufficient to reduce marked obesity and needs to 
be further investigated.  
 
Dogs and cats 
When exposed to ad libitum high-fat feeding, dogs often develop an increase in body fat (Backus 
et al., 2007) (Nguyen et al., 2004). However not all studies in dogs and cats showed that ad 
libitum exposure to food resulted in obesity, perhaps similar to the situation in diet resistant 
rodents. It seems however, that more frequent feeding might increase the risk of developing 
body weight gain and obesity in cats (Colliard et al., 2006; Courcier et al., 2010). Most studies 
suggest that the higher the dietary fat content, the greater body fat accumulation in companion 
animals will be. 
Like in humans, the primary care strategy to treat obesity in companion animals is by applying 
an energy restriction diet. An important concern with energy restricted diets, however, is that the 
amount of calories needed to induce weight loss and for the long-term maintenance of energy 
balance can greatly differ among individual animals (Laflamme, 1997) (Butterwick and 
Hawthorne, 1998). Too dramatic reductions in total food supply may result in a deficiency of 
essential nutrients; therefore, it is important that the appropriate diet for body weight loss covers 
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all these requirements and that the adjustment in calorie allowance is made on a regular basis in 
order to preserve the fat free mass (Laflamme, 2012). 
The consumption of low-calorie diets with increased protein content during weight loss programs 
has been shown to increase fat loss while maintaining lean body mass in both cats and dogs 
(Laflamme, 2006). Because of its stronger effect on diet induced thermogenesis, protein intake 
may induce an increase in energy expenditure which results in a minor but significant increase in 
total daily energy expenditure in subjects fed high-protein diets (Mikkelsen et al., 2000; Wei et 
al., 2011). The consumption of high-protein diets has also been demonstrated to limit the 
decrease in resting energy expenditure which is a typical metabolic adaptation observed during 
caloric restriction (Rosenbaum et al., 2008; Schwartz et al., 2003). Hence, higher protein diets 
may help to maintain body weight loss and prevent weight regain. In cats, high-protein diets 
during weight loss also help to reduce oxidative stress and chronic inflammation associated with 
obesity (Laflamme, 2012). 
Dietary fibers provide less dietary energy due to their lower digestibility than fat or 
carbohydrates. Cats fed with combinations of diets high in fiber and water decreased their 
caloric intake which may also contribute to weight loss (Morris et al., 2006); hence, the 
enhanced satiety provided by dietary fiber may help to reduce caloric intake and be useful in the 
prevention and treatment of both obesity and diabetes mellitus (de Godoy et al., 2013). 
 
Among the many compounds which have been evaluated for the use in weight management in 
companion animals, soy isoflavones have been shown to increase lean body mass in cats (Cave 
et al., 2007b) (Cave et al., 2007a) and to reduce the post-neutering weight gain in dogs 
(Laflamme, 2012). In humans, dietary isoflavone supplementation also reduced the risk of 
developing metabolic disorders such as cardiovascular diseases, diabetes, and obesity 
(Bhathena and Velasquez, 2002) and seemed to improve fasting insulin levels and insulin 
resistance in postmenopausal diabetic women (Jayagopal et al., 2002). Further, diacylglycerols 
and carnitine have also been proposed to improve rates of weight loss and to be of help in body 
weight management in both dogs and cats (Laflamme, 2012; Mitsuhashi et al., 2012). Similarly 
to humans and rodents (Hibi et al., 2008) (Murase et al., 2001), the mechanism of action of 
diacylglycerols was suggested to be linked to an increase in fat oxidation and to a lowering of 
serum triacylglycerol levels postprandially which may result in increased satiety (Rudkowska et 
al., 2005).  
 
4.6 Gut microbiota 
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Studies in humans and mice have shown that alterations of the gastrointestinal microbiota are 
associated with the development of fat mass, insulin resistance and low-grade inflammation in 
conjunction with obesity (Backhed et al., 2004; Ley et al., 2005). By modulating the capacity to 
harvest energy from indigestible dietary polysaccharides or other nutrients, gut microflora may 
affect the host metabolism and the host’s control of body weight and energy homeostasis 
(Turnbaugh et al., 2006). Numerous experiments indicate that changes in microbiota may 
actually be causally related to the development of obesity, and not be a mere consequence (see 
below). 
Further, the fat content of food has been shown to change the composition of intestinal 
microbiota and to modulate the metabolic concentrations of plasma LPS in mice. It appears, in 
fact, that changes in the fat content of the diet may alter the mechanisms of LPS absorption from 
intestinal microbiota through the intestinal epithelium and to increase the transfer of intestinal 
LPS into lymph (Cani et al., 2007a). In accordance with this hypothesis, it has been 
demonstrated that the specific modulation of the gut microbiota by means of antibiotic treatment 
and prebiotic nutrients decreased the effect of high-fat diet-induced metabolic endotoxemia and 
subsequently reduced inflammatory disorders in high-fat fed mice (Cani et al., 2008; Cani et al., 
2007b). Further, weight loss achieved by dieting (Duncan et al., 2008) or surgically through 
gastric bypass reverses the obesity or high fat feeding induced changes in the gut microflora 
(Cani et al., 2012; Liou et al., 2013; Osto et al., 2013).  
 
A causal relationship between alterations in intestinal microbiota and the control of body weight 
has been demonstrated in rodent models. Transplanting intestinal microbiota from obese mice to 
lean recipients increased the adiposity of the recipients; further, recipient germ free mice that 
received gut microbiota from obese versus lean donors differed markedly in their adiposity. 
Changes in intestinal microbial populations have also been shown to improve the metabolic 
phenotype of human patients with metabolic syndrome. In fact, transplantation of the gut 
microbiota from lean donors to patients with metabolic syndrome resulted in improved insulin 
sensitivity (Qin et al., 2012; Vrieze et al., 2012). The mechanisms involved are not defined but 
may involve direct modulations of the immune system (Cani et al., 2007a; Everard et al., 2014). 
Consistent with the important role of gut microbiota in a number of metabolic diseases, gut 
microbial gene profiling has been shown to help distinguishing type 2 diabetic subjects from 
control subjects with a predictive power far better than that of the body mass index (Karlsson et 
al., 2013). 
 
Dogs and cats 
24 
 
In dogs and cats, the overall composition of the intestinal bacteria is generally similar to that 
found in other mammals. Further, canine and feline gut microbiota can be modulated by dietary 
intervention and antimicrobial therapy but also depend on the host’s age (Barry et al., 2012; 
Garcia-Mazcorro et al., 2011). Data characterizing the intestinal microbiota in diseased states 
are currently poorly available in companion animals. Clinical studies suggest the presence of a 
dysbiosis in inflammatory bowel disease (Inness et al., 2007). However, only one study has 
been published on the composition of the faecal microbiota of lean versus obese pet dogs. The 
study population of research dogs was small, and the inter-individual variation was high (Handl 
et al., 2013). No such studies have been published in cats yet, though it has been shown 
recently that surprisingly, the faecal microbiota composition of insulin-treated, diabetic cats did 
not differ from that of non-diabetic cats. Furthermore, no associations were found between 
changes in faecal microbiota composition and cat breed or gender, dietary protein, carbohydrate 
or fat content, or dietary formulation (Bell et al., 2014). Further studies are required to increase 
our understanding of the role of gut microbiota in diseases such obesity and diabetes in 
companion animals.  
 
 
5. Summary 
Obesity is not a “simple accumulation” of fat but it leads to impaired general heath which may be 
associated with metabolic disorders such as type 2 diabetes mellitus, hyperlipidemia, 
hypertension and cardiovascular diseases. Animal models provide invaluable tools to study the 
underlying mechanisms of obesity, of its comorbidities and potential therapeutic options. Most 
research has traditionally been done in rodents but other species, including dogs and cats, may 
offer additional benefit because they may spontaneously develop obesity induced changes 
which typically do not occur in common rodent models of obesity. To name just one example, 
cats are a much better model for human type 2 diabetes than most rodents because they 
develop the full pathophysiology, including pancreatic islet amyloid deposition. Unfortunately, the 
array of available techniques and tools is still restricted in dogs and cats compared to rodents; 
this refers to classical laboratory techniques, but in particular also to techniques of genetic 
manipulation. Hence, even though physiological and pathophysiological phenomena are well 
described in dogs and cats, the underlying mechanisms are often not known and studies 
investigating causality are scarce. 
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Dear colleagues, 
 
 
We want to thank you again for giving us the opportunity to contribute to the Special Issue of the 
European Journal of Pharmacology. Please find our paper entitled “Translational Value of Animal 
Models of Obesity - Focus on dogs and cats” for consideration. As you will see, we decided to 
focus more specifically on these two species when describing their benefits and potential 
shortcomings as animal models of obesity. For that reason, you may consider our contribution for the 
“species-specific” section of the Special Issue. We hope that yourself and the reviewers of our 
contribution will evaluate our manuscript positively and we are looking forward to hearing from you 
soon. 
 
Merry Christmas and best wishes 
 
 
 
Thomas Lutz and Melania Osto 
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